The global market for Citalopram Hydrobromide Tablets was valued at US$ 124 million in the year 2024 and is projected to reach a revised size of US$ 163 million by 2031, growing at a CAGR of 4.0% during the forecast period.

Citalopram Hydrobromide Tablets Market

Citalopram is a strong selective serotonin reuptake inhibitor (SSRI) antidepressant

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Citalopram Hydrobromide Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Citalopram Hydrobromide Tablets.

The Citalopram Hydrobromide Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Citalopram Hydrobromide Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Citalopram Hydrobromide Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Citalopram Hydrobromide Tablets Market Report

Report Metric	Details
Report Name	Citalopram Hydrobromide Tablets Market
Accounted market size in year	US$ 124 million
Forecasted market size in 2031	US$ 163 million
CAGR	4.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	12 Tablets/Box 14 Tablets/Box
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Kelun Pharmaceutical, Enhua Pharmaceutical, Yinuo Medicine, SHODHANA, Cipla Inc., Mahban Group, Virupaksha, Index Pharmaceutical, Northeast Pharmaceutical Group, China Resources Sanjiu Pharmaceutical, Hanhui Pharmaceutical, Southwest Pharmaceutical, H. Lundbeck
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Citalopram Hydrobromide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Citalopram Hydrobromide Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Citalopram Hydrobromide Tablets Market growing?

Ans: The Citalopram Hydrobromide Tablets Market witnessing a CAGR of 4.0% during the forecast period 2025-2031.

What is the Citalopram Hydrobromide Tablets Market size in 2031?

Ans: The Citalopram Hydrobromide Tablets Market size in 2031 will be US$ 163 million.

Who are the main players in the Citalopram Hydrobromide Tablets Market report?

Ans: The main players in the Citalopram Hydrobromide Tablets Market are Kelun Pharmaceutical, Enhua Pharmaceutical, Yinuo Medicine, SHODHANA, Cipla Inc., Mahban Group, Virupaksha, Index Pharmaceutical, Northeast Pharmaceutical Group, China Resources Sanjiu Pharmaceutical, Hanhui Pharmaceutical, Southwest Pharmaceutical, H. Lundbeck

What are the Application segmentation covered in the Citalopram Hydrobromide Tablets Market report?

Ans: The Applications covered in the Citalopram Hydrobromide Tablets Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Citalopram Hydrobromide Tablets Market report?

Ans: The Types covered in the Citalopram Hydrobromide Tablets Market report are 12 Tablets/Box, 14 Tablets/Box

1 Citalopram Hydrobromide Tablets Market Overview

1.1 Product Definition

1.2 Citalopram Hydrobromide Tablets by Type

1.2.1 Global Citalopram Hydrobromide Tablets Market Value Comparison by Type (2024 VS 2031)

1.2.2 12 Tablets/Box

1.2.3 14 Tablets/Box

1.3 Citalopram Hydrobromide Tablets by Application

1.3.1 Global Citalopram Hydrobromide Tablets Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Citalopram Hydrobromide Tablets Market Size Estimates and Forecasts

1.4.1 Global Citalopram Hydrobromide Tablets Revenue 2020-2031

1.4.2 Global Citalopram Hydrobromide Tablets Sales 2020-2031

1.4.3 Global Citalopram Hydrobromide Tablets Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Citalopram Hydrobromide Tablets Market Competition by Manufacturers

2.1 Global Citalopram Hydrobromide Tablets Sales Market Share by Manufacturers (2020-2025)

2.2 Global Citalopram Hydrobromide Tablets Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Citalopram Hydrobromide Tablets Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Citalopram Hydrobromide Tablets, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Citalopram Hydrobromide Tablets, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Citalopram Hydrobromide Tablets, Product Type & Application

2.7 Global Key Manufacturers of Citalopram Hydrobromide Tablets, Date of Enter into This Industry

2.8 Global Citalopram Hydrobromide Tablets Market Competitive Situation and Trends

2.8.1 Global Citalopram Hydrobromide Tablets Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Citalopram Hydrobromide Tablets Players Market Share by Revenue

2.8.3 Global Citalopram Hydrobromide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Citalopram Hydrobromide Tablets Market Scenario by Region

3.1 Global Citalopram Hydrobromide Tablets Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Citalopram Hydrobromide Tablets Sales by Region: 2020-2031

3.2.1 Global Citalopram Hydrobromide Tablets Sales by Region: 2020-2025

3.2.2 Global Citalopram Hydrobromide Tablets Sales by Region: 2026-2031

3.3 Global Citalopram Hydrobromide Tablets Revenue by Region: 2020-2031

3.3.1 Global Citalopram Hydrobromide Tablets Revenue by Region: 2020-2025

3.3.2 Global Citalopram Hydrobromide Tablets Revenue by Region: 2026-2031

3.4 North America Citalopram Hydrobromide Tablets Market Facts & Figures by Country

3.4.1 North America Citalopram Hydrobromide Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Citalopram Hydrobromide Tablets Sales by Country (2020-2031)

3.4.3 North America Citalopram Hydrobromide Tablets Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Citalopram Hydrobromide Tablets Market Facts & Figures by Country

3.5.1 Europe Citalopram Hydrobromide Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Citalopram Hydrobromide Tablets Sales by Country (2020-2031)

3.5.3 Europe Citalopram Hydrobromide Tablets Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Citalopram Hydrobromide Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Citalopram Hydrobromide Tablets Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Citalopram Hydrobromide Tablets Sales by Region (2020-2031)

3.6.3 Asia Pacific Citalopram Hydrobromide Tablets Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Citalopram Hydrobromide Tablets Market Facts & Figures by Country

3.7.1 Latin America Citalopram Hydrobromide Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Citalopram Hydrobromide Tablets Sales by Country (2020-2031)

3.7.3 Latin America Citalopram Hydrobromide Tablets Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Citalopram Hydrobromide Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Citalopram Hydrobromide Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Citalopram Hydrobromide Tablets Sales by Country (2020-2031)

3.8.3 Middle East and Africa Citalopram Hydrobromide Tablets Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Citalopram Hydrobromide Tablets Sales by Type (2020-2031)

4.1.1 Global Citalopram Hydrobromide Tablets Sales by Type (2020-2025)

4.1.2 Global Citalopram Hydrobromide Tablets Sales by Type (2026-2031)

4.1.3 Global Citalopram Hydrobromide Tablets Sales Market Share by Type (2020-2031)

4.2 Global Citalopram Hydrobromide Tablets Revenue by Type (2020-2031)

4.2.1 Global Citalopram Hydrobromide Tablets Revenue by Type (2020-2025)

4.2.2 Global Citalopram Hydrobromide Tablets Revenue by Type (2026-2031)

4.2.3 Global Citalopram Hydrobromide Tablets Revenue Market Share by Type (2020-2031)

4.3 Global Citalopram Hydrobromide Tablets Price by Type (2020-2031)

5 Segment by Application

5.1 Global Citalopram Hydrobromide Tablets Sales by Application (2020-2031)

5.1.1 Global Citalopram Hydrobromide Tablets Sales by Application (2020-2025)

5.1.2 Global Citalopram Hydrobromide Tablets Sales by Application (2026-2031)

5.1.3 Global Citalopram Hydrobromide Tablets Sales Market Share by Application (2020-2031)

5.2 Global Citalopram Hydrobromide Tablets Revenue by Application (2020-2031)

5.2.1 Global Citalopram Hydrobromide Tablets Revenue by Application (2020-2025)

5.2.2 Global Citalopram Hydrobromide Tablets Revenue by Application (2026-2031)

5.2.3 Global Citalopram Hydrobromide Tablets Revenue Market Share by Application (2020-2031)

5.3 Global Citalopram Hydrobromide Tablets Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Kelun Pharmaceutical

6.1.1 Kelun Pharmaceutical Company Information

6.1.2 Kelun Pharmaceutical Description and Business Overview

6.1.3 Kelun Pharmaceutical Citalopram Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Kelun Pharmaceutical Citalopram Hydrobromide Tablets Product Portfolio

6.1.5 Kelun Pharmaceutical Recent Developments/Updates

6.2 Enhua Pharmaceutical

6.2.1 Enhua Pharmaceutical Company Information

6.2.2 Enhua Pharmaceutical Description and Business Overview

6.2.3 Enhua Pharmaceutical Citalopram Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Enhua Pharmaceutical Citalopram Hydrobromide Tablets Product Portfolio

6.2.5 Enhua Pharmaceutical Recent Developments/Updates

6.3 Yinuo Medicine

6.3.1 Yinuo Medicine Company Information

6.3.2 Yinuo Medicine Description and Business Overview

6.3.3 Yinuo Medicine Citalopram Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Yinuo Medicine Citalopram Hydrobromide Tablets Product Portfolio

6.3.5 Yinuo Medicine Recent Developments/Updates

6.4 SHODHANA

6.4.1 SHODHANA Company Information

6.4.2 SHODHANA Description and Business Overview

6.4.3 SHODHANA Citalopram Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.4.4 SHODHANA Citalopram Hydrobromide Tablets Product Portfolio

6.4.5 SHODHANA Recent Developments/Updates

6.5 Cipla Inc.

6.5.1 Cipla Inc. Company Information

6.5.2 Cipla Inc. Description and Business Overview

6.5.3 Cipla Inc. Citalopram Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Cipla Inc. Citalopram Hydrobromide Tablets Product Portfolio

6.5.5 Cipla Inc. Recent Developments/Updates

6.6 Mahban Group

6.6.1 Mahban Group Company Information

6.6.2 Mahban Group Description and Business Overview

6.6.3 Mahban Group Citalopram Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Mahban Group Citalopram Hydrobromide Tablets Product Portfolio

6.6.5 Mahban Group Recent Developments/Updates

6.7 Virupaksha

6.7.1 Virupaksha Company Information

6.7.2 Virupaksha Description and Business Overview

6.7.3 Virupaksha Citalopram Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Virupaksha Citalopram Hydrobromide Tablets Product Portfolio

6.7.5 Virupaksha Recent Developments/Updates

6.8 Index Pharmaceutical

6.8.1 Index Pharmaceutical Company Information

6.8.2 Index Pharmaceutical Description and Business Overview

6.8.3 Index Pharmaceutical Citalopram Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Index Pharmaceutical Citalopram Hydrobromide Tablets Product Portfolio

6.8.5 Index Pharmaceutical Recent Developments/Updates

6.9 Northeast Pharmaceutical Group

6.9.1 Northeast Pharmaceutical Group Company Information

6.9.2 Northeast Pharmaceutical Group Description and Business Overview

6.9.3 Northeast Pharmaceutical Group Citalopram Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Northeast Pharmaceutical Group Citalopram Hydrobromide Tablets Product Portfolio

6.9.5 Northeast Pharmaceutical Group Recent Developments/Updates

6.10 China Resources Sanjiu Pharmaceutical

6.10.1 China Resources Sanjiu Pharmaceutical Company Information

6.10.2 China Resources Sanjiu Pharmaceutical Description and Business Overview

6.10.3 China Resources Sanjiu Pharmaceutical Citalopram Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.10.4 China Resources Sanjiu Pharmaceutical Citalopram Hydrobromide Tablets Product Portfolio

6.10.5 China Resources Sanjiu Pharmaceutical Recent Developments/Updates

6.11 Hanhui Pharmaceutical

6.11.1 Hanhui Pharmaceutical Company Information

6.11.2 Hanhui Pharmaceutical Description and Business Overview

6.11.3 Hanhui Pharmaceutical Citalopram Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Hanhui Pharmaceutical Citalopram Hydrobromide Tablets Product Portfolio

6.11.5 Hanhui Pharmaceutical Recent Developments/Updates

6.12 Southwest Pharmaceutical

6.12.1 Southwest Pharmaceutical Company Information

6.12.2 Southwest Pharmaceutical Description and Business Overview

6.12.3 Southwest Pharmaceutical Citalopram Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Southwest Pharmaceutical Citalopram Hydrobromide Tablets Product Portfolio

6.12.5 Southwest Pharmaceutical Recent Developments/Updates

6.13 H. Lundbeck

6.13.1 H. Lundbeck Company Information

6.13.2 H. Lundbeck Description and Business Overview

6.13.3 H. Lundbeck Citalopram Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.13.4 H. Lundbeck Citalopram Hydrobromide Tablets Product Portfolio

6.13.5 H. Lundbeck Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Citalopram Hydrobromide Tablets Industry Chain Analysis

7.2 Citalopram Hydrobromide Tablets Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Citalopram Hydrobromide Tablets Production Mode & Process Analysis

7.4 Citalopram Hydrobromide Tablets Sales and Marketing

7.4.1 Citalopram Hydrobromide Tablets Sales Channels

7.4.2 Citalopram Hydrobromide Tablets Distributors

7.5 Citalopram Hydrobromide Tablets Customer Analysis

8 Citalopram Hydrobromide Tablets Market Dynamics

8.1 Citalopram Hydrobromide Tablets Industry Trends

8.2 Citalopram Hydrobromide Tablets Market Drivers

8.3 Citalopram Hydrobromide Tablets Market Challenges

8.4 Citalopram Hydrobromide Tablets Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Northeast Pharmaceutical Group

China Resources Sanjiu Pharmaceutical

Hanhui Pharmaceutical

Southwest Pharmaceutical

H.Lundbeck

Yinuo Medicine

List of Tables

Table 1. Global Citalopram Hydrobromide Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Citalopram Hydrobromide Tablets Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Citalopram Hydrobromide Tablets Market Competitive Situation by Manufacturers in 2024

Table 4. Global Citalopram Hydrobromide Tablets Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Citalopram Hydrobromide Tablets Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Citalopram Hydrobromide Tablets Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Citalopram Hydrobromide Tablets Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Citalopram Hydrobromide Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Citalopram Hydrobromide Tablets, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Citalopram Hydrobromide Tablets, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Citalopram Hydrobromide Tablets, Product Type & Application

Table 12. Global Key Manufacturers of Citalopram Hydrobromide Tablets, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Citalopram Hydrobromide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Citalopram Hydrobromide Tablets as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Citalopram Hydrobromide Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Citalopram Hydrobromide Tablets Sales by Region (2020-2025) & (K Units)

Table 18. Global Citalopram Hydrobromide Tablets Sales Market Share by Region (2020-2025)

Table 19. Global Citalopram Hydrobromide Tablets Sales by Region (2026-2031) & (K Units)

Table 20. Global Citalopram Hydrobromide Tablets Sales Market Share by Region (2026-2031)

Table 21. Global Citalopram Hydrobromide Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Citalopram Hydrobromide Tablets Revenue Market Share by Region (2020-2025)

Table 23. Global Citalopram Hydrobromide Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Citalopram Hydrobromide Tablets Revenue Market Share by Region (2026-2031)

Table 25. North America Citalopram Hydrobromide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Citalopram Hydrobromide Tablets Sales by Country (2020-2025) & (K Units)

Table 27. North America Citalopram Hydrobromide Tablets Sales by Country (2026-2031) & (K Units)

Table 28. North America Citalopram Hydrobromide Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Citalopram Hydrobromide Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Citalopram Hydrobromide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Citalopram Hydrobromide Tablets Sales by Country (2020-2025) & (K Units)

Table 32. Europe Citalopram Hydrobromide Tablets Sales by Country (2026-2031) & (K Units)

Table 33. Europe Citalopram Hydrobromide Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Citalopram Hydrobromide Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Citalopram Hydrobromide Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Citalopram Hydrobromide Tablets Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Citalopram Hydrobromide Tablets Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Citalopram Hydrobromide Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Citalopram Hydrobromide Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Citalopram Hydrobromide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Citalopram Hydrobromide Tablets Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Citalopram Hydrobromide Tablets Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Citalopram Hydrobromide Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Citalopram Hydrobromide Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Citalopram Hydrobromide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Citalopram Hydrobromide Tablets Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Citalopram Hydrobromide Tablets Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Citalopram Hydrobromide Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Citalopram Hydrobromide Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Citalopram Hydrobromide Tablets Sales (K Units) by Type (2020-2025)

Table 51. Global Citalopram Hydrobromide Tablets Sales (K Units) by Type (2026-2031)

Table 52. Global Citalopram Hydrobromide Tablets Sales Market Share by Type (2020-2025)

Table 53. Global Citalopram Hydrobromide Tablets Sales Market Share by Type (2026-2031)

Table 54. Global Citalopram Hydrobromide Tablets Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Citalopram Hydrobromide Tablets Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Citalopram Hydrobromide Tablets Revenue Market Share by Type (2020-2025)

Table 57. Global Citalopram Hydrobromide Tablets Revenue Market Share by Type (2026-2031)

Table 58. Global Citalopram Hydrobromide Tablets Price (US$/Unit) by Type (2020-2025)

Table 59. Global Citalopram Hydrobromide Tablets Price (US$/Unit) by Type (2026-2031)

Table 60. Global Citalopram Hydrobromide Tablets Sales (K Units) by Application (2020-2025)

Table 61. Global Citalopram Hydrobromide Tablets Sales (K Units) by Application (2026-2031)

Table 62. Global Citalopram Hydrobromide Tablets Sales Market Share by Application (2020-2025)

Table 63. Global Citalopram Hydrobromide Tablets Sales Market Share by Application (2026-2031)

Table 64. Global Citalopram Hydrobromide Tablets Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Citalopram Hydrobromide Tablets Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Citalopram Hydrobromide Tablets Revenue Market Share by Application (2020-2025)

Table 67. Global Citalopram Hydrobromide Tablets Revenue Market Share by Application (2026-2031)

Table 68. Global Citalopram Hydrobromide Tablets Price (US$/Unit) by Application (2020-2025)

Table 69. Global Citalopram Hydrobromide Tablets Price (US$/Unit) by Application (2026-2031)

Table 70. Kelun Pharmaceutical Company Information

Table 71. Kelun Pharmaceutical Description and Business Overview

Table 72. Kelun Pharmaceutical Citalopram Hydrobromide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Kelun Pharmaceutical Citalopram Hydrobromide Tablets Product

Table 74. Kelun Pharmaceutical Recent Developments/Updates

Table 75. Enhua Pharmaceutical Company Information

Table 76. Enhua Pharmaceutical Description and Business Overview

Table 77. Enhua Pharmaceutical Citalopram Hydrobromide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Enhua Pharmaceutical Citalopram Hydrobromide Tablets Product

Table 79. Enhua Pharmaceutical Recent Developments/Updates

Table 80. Yinuo Medicine Company Information

Table 81. Yinuo Medicine Description and Business Overview

Table 82. Yinuo Medicine Citalopram Hydrobromide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Yinuo Medicine Citalopram Hydrobromide Tablets Product

Table 84. Yinuo Medicine Recent Developments/Updates

Table 85. SHODHANA Company Information

Table 86. SHODHANA Description and Business Overview

Table 87. SHODHANA Citalopram Hydrobromide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. SHODHANA Citalopram Hydrobromide Tablets Product

Table 89. SHODHANA Recent Developments/Updates

Table 90. Cipla Inc. Company Information

Table 91. Cipla Inc. Description and Business Overview

Table 92. Cipla Inc. Citalopram Hydrobromide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Cipla Inc. Citalopram Hydrobromide Tablets Product

Table 94. Cipla Inc. Recent Developments/Updates

Table 95. Mahban Group Company Information

Table 96. Mahban Group Description and Business Overview

Table 97. Mahban Group Citalopram Hydrobromide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Mahban Group Citalopram Hydrobromide Tablets Product

Table 99. Mahban Group Recent Developments/Updates

Table 100. Virupaksha Company Information

Table 101. Virupaksha Description and Business Overview

Table 102. Virupaksha Citalopram Hydrobromide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Virupaksha Citalopram Hydrobromide Tablets Product

Table 104. Virupaksha Recent Developments/Updates

Table 105. Index Pharmaceutical Company Information

Table 106. Index Pharmaceutical Description and Business Overview

Table 107. Index Pharmaceutical Citalopram Hydrobromide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Index Pharmaceutical Citalopram Hydrobromide Tablets Product

Table 109. Index Pharmaceutical Recent Developments/Updates

Table 110. Northeast Pharmaceutical Group Company Information

Table 111. Northeast Pharmaceutical Group Description and Business Overview

Table 112. Northeast Pharmaceutical Group Citalopram Hydrobromide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Northeast Pharmaceutical Group Citalopram Hydrobromide Tablets Product

Table 114. Northeast Pharmaceutical Group Recent Developments/Updates

Table 115. China Resources Sanjiu Pharmaceutical Company Information

Table 116. China Resources Sanjiu Pharmaceutical Description and Business Overview

Table 117. China Resources Sanjiu Pharmaceutical Citalopram Hydrobromide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. China Resources Sanjiu Pharmaceutical Citalopram Hydrobromide Tablets Product

Table 119. China Resources Sanjiu Pharmaceutical Recent Developments/Updates

Table 120. Hanhui Pharmaceutical Company Information

Table 121. Hanhui Pharmaceutical Description and Business Overview

Table 122. Hanhui Pharmaceutical Citalopram Hydrobromide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Hanhui Pharmaceutical Citalopram Hydrobromide Tablets Product

Table 124. Hanhui Pharmaceutical Recent Developments/Updates

Table 125. Southwest Pharmaceutical Company Information

Table 126. Southwest Pharmaceutical Description and Business Overview

Table 127. Southwest Pharmaceutical Citalopram Hydrobromide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Southwest Pharmaceutical Citalopram Hydrobromide Tablets Product

Table 129. Southwest Pharmaceutical Recent Developments/Updates

Table 130. H. Lundbeck Company Information

Table 131. H. Lundbeck Description and Business Overview

Table 132. H. Lundbeck Citalopram Hydrobromide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. H. Lundbeck Citalopram Hydrobromide Tablets Product

Table 134. H. Lundbeck Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Citalopram Hydrobromide Tablets Distributors List

Table 138. Citalopram Hydrobromide Tablets Customers List

Table 139. Citalopram Hydrobromide Tablets Market Trends

Table 140. Citalopram Hydrobromide Tablets Market Drivers

Table 141. Citalopram Hydrobromide Tablets Market Challenges

Table 142. Citalopram Hydrobromide Tablets Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Citalopram Hydrobromide Tablets

Figure 2. Global Citalopram Hydrobromide Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Citalopram Hydrobromide Tablets Market Share by Type: 2024 & 2031

Figure 4. 12 Tablets/Box Product Picture

Figure 5. 14 Tablets/Box Product Picture

Figure 6. Global Citalopram Hydrobromide Tablets Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Citalopram Hydrobromide Tablets Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Other

Figure 11. Global Citalopram Hydrobromide Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Citalopram Hydrobromide Tablets Market Size (2020-2031) & (US$ Million)

Figure 13. Global Citalopram Hydrobromide Tablets Sales (2020-2031) & (K Units)

Figure 14. Global Citalopram Hydrobromide Tablets Average Price (US$/Unit) & (2020-2031)

Figure 15. Citalopram Hydrobromide Tablets Report Years Considered

Figure 16. Citalopram Hydrobromide Tablets Sales Share by Manufacturers in 2024

Figure 17. Global Citalopram Hydrobromide Tablets Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Citalopram Hydrobromide Tablets Players: Market Share by Revenue in Citalopram Hydrobromide Tablets in 2024

Figure 19. Citalopram Hydrobromide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Citalopram Hydrobromide Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Citalopram Hydrobromide Tablets Sales Market Share by Country (2020-2031)

Figure 22. North America Citalopram Hydrobromide Tablets Revenue Market Share by Country (2020-2031)

Figure 23. United States Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Citalopram Hydrobromide Tablets Sales Market Share by Country (2020-2031)

Figure 26. Europe Citalopram Hydrobromide Tablets Revenue Market Share by Country (2020-2031)

Figure 27. Germany Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Citalopram Hydrobromide Tablets Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Citalopram Hydrobromide Tablets Revenue Market Share by Region (2020-2031)

Figure 34. China Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Citalopram Hydrobromide Tablets Sales Market Share by Country (2020-2031)

Figure 42. Latin America Citalopram Hydrobromide Tablets Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Middle East and Africa Citalopram Hydrobromide Tablets Sales Market Share by Country (2020-2031)

Figure 47. Middle East and Africa Citalopram Hydrobromide Tablets Revenue Market Share by Country (2020-2031)

Figure 48. Turkey Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. UAE Citalopram Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Global Sales Market Share of Citalopram Hydrobromide Tablets by Type (2020-2031)

Figure 52. Global Revenue Market Share of Citalopram Hydrobromide Tablets by Type (2020-2031)

Figure 53. Global Citalopram Hydrobromide Tablets Price (US$/Unit) by Type (2020-2031)

Figure 54. Global Sales Market Share of Citalopram Hydrobromide Tablets by Application (2020-2031)

Figure 55. Global Revenue Market Share of Citalopram Hydrobromide Tablets by Application (2020-2031)

Figure 56. Global Citalopram Hydrobromide Tablets Price (US$/Unit) by Application (2020-2031)

Figure 57. Citalopram Hydrobromide Tablets Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions